RAMSAY GENERALE DE SANTE financials
RAMSAY GENERALE DE SANTE
Country: FR Reporting currency: EUR Latest annual report: 2025-06-30
LEI:
969500I1EJGUAT223F44 Financial statements
(EUR, as reported — unscaled; 106 line items across 2 annual periods)
| Line item | 2025 | 2024 |
|---|---|---|
| Income statement | ||
| Revenue | €5.24B | €5.01B |
| Employee benefits expense | €2.66B | €2.57B |
| Raw materials & consumables used | €1.16B | €1.06B |
| Depreciation & amortisation | €434.0M | €426.7M |
| Operating profit (EBIT) | €173.2M | €160.6M |
| Income tax expense | €1.6M | -€4.1M |
| Profit for the year | -€38.1M | -€36.7M |
| — attributable to owners | -€54.1M | -€53.9M |
| — attributable to NCI | €16.0M | €17.2M |
| Total comprehensive income | -€33.1M | -€34.4M |
| Per share | ||
| Basic EPS | €-0.49 | €-0.49 |
| Diluted EPS | €-0.49 | €-0.49 |
| Cash flow statement | ||
| Net cash from operating activities | €693.7M | €586.8M |
| Net cash from investing activities | -€138.4M | -€180.5M |
| Net cash from financing activities | -€550.2M | -€401.5M |
| Dividends paid | €14.4M | €13.4M |
| Proceeds from borrowings | €63.1M | €70.4M |
| Repayments of borrowings | €148.2M | €56.0M |
| Lease liability payments | €251.6M | €230.7M |
| Balance sheet | ||
| Total assets | €6.84B | €6.90B |
| Non-current assets | €5.53B | €5.43B |
| Property, plant & equipment | €936.0M | €974.4M |
| Right-of-use assets | €2.03B | €1.93B |
| Intangible assets & goodwill | €2.09B | €2.08B |
| Inventories | €125.1M | €125.0M |
| Trade & other receivables | €527.5M | €687.2M |
| Cash & equivalents | €366.5M | €359.0M |
| Total equity | €1.18B | €1.23B |
| — attributable to owners | €1.15B | €1.19B |
| Non-controlling interests | €36.6M | €35.4M |
| Non-current liabilities | €4.04B | €3.98B |
| Long-term borrowings | €1.84B | €1.88B |
| Lease liabilities (non-current) | €1.89B | €1.80B |
| Lease liabilities (current) | €268.7M | €245.1M |
| Deferred tax liabilities | €29.4M | €17.2M |
| Derived metrics | ||
| Operating margin | 3.3% | 3.2% |
| Net margin | -0.7% | -0.7% |
| Return on equity | -3.2% | -3.0% |
| Cash conversion ratio | -18.21× | -15.99× |
| Other reported items | ||
| Adjustments For Depreciation and Amortisation Expense | €434.0M | €426.7M |
| Adjustments For Income Tax Expense | €1.6M | -€4.1M |
| Adjustments For Undistributed Profits of Investments Accounted For Using Equity Method | €0 | €0 |
| Cash Flows From Losing Control of Subsidiaries Or Other Businesses Classified As Investing Activities | €1.3M | €2.0M |
| Cash Flows From Used In Financing Activities Discontinued Operations | €2.2M | €0 |
| Cash Flows From Used In Investing Activities Discontinued Operations | -€400.0K | €0 |
| Cash Flows From Used In Operating Activities Discontinued Operations | -€1.8M | €0 |
| Cash Flows From Used In Operations Before Changes In Working Capital | €578.0M | €561.9M |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | €5.1M | €16.3M |
| Comprehensive Income Attributable To Noncontrolling Interests | €16.0M | €17.2M |
| Comprehensive Income Attributable To Owners of Parent | -€49.1M | -€51.6M |
| Current Assets Other Than Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners | €1.30B | €1.47B |
| Current Borrowings and Current Portion of Noncurrent Borrowings | €61.0M | €104.3M |
| Current Financial Assets | €17.5M | €22.3M |
| Current Liabilities Other Than Liabilities Included In Disposal Groups Classified As Held For Sale | €1.62B | €1.69B |
| Current Provisions | €33.6M | €36.4M |
| Current Tax Assets Current | €6.3M | €3.8M |
| Current Tax Liabilities Current | €5.4M | €5.1M |
| Deferred Tax Assets | €114.7M | €91.6M |
| Dividends Paid To Noncontrolling Interests Classified As Financing Activities | €14.4M | €13.4M |
| Dividends Received Classified As Investing Activities | €1.6M | €400.0K |
| Dividends Recognised As Distributions To Owners Per Share | €0.00 | — |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | €2.4M | €2.0M |
| Equity and Liabilities | €6.84B | €6.90B |
| Income Taxes Paid Refund Classified As Operating Activities | €17.9M | €1.3M |
| Increase Decrease In Cash and Cash Equivalents | €5.1M | €4.8M |
| Increase Decrease In Working Capital | -€135.4M | -€26.2M |
| Increase Decrease Through Appropriation of Retained Earnings | €0 | €0 |
| Increase Decrease Through Sharebased Payment Transactions | €0 | €0 |
| Increase Decrease Through Transfers and Other Changes Equity | -€400.0K | €600.0K |
| Increase Decrease Through Treasury Share Transactions | €0 | €0 |
| Intangible Assets Other Than Goodwill | €205.5M | €209.0M |
| Interest Expense On Lease Liabilities | €80.1M | €80.2M |
| Interest Income On Cash and Cash Equivalents | €4.7M | €2.9M |
| Investment Accounted For Using Equity Method | €200.0K | €200.0K |
| Issue of Equity | €0 | €0 |
| Issued Capital | €82.7M | €82.7M |
| Liabilities Included In Disposal Groups Classified As Held For Sale | €3.3M | €0 |
| Noncurrent Assets Or Disposal Groups Classified As Held For Sale | €2.9M | €0 |
| Noncurrent Provisions For Employee Benefits | €102.9M | €107.6M |
| Other Adjustments For Noncash Items | -€4.2M | -€12.7M |
| Other Comprehensive Income | €5.0M | €2.3M |
| Other Comprehensive Income Net of Tax Cash Flow Hedges | -€9.9M | -€2.7M |
| Other Comprehensive Income Net of Tax Exchange Differences On Translation | €9.5M | €16.0M |
| Other Comprehensive Income Net of Tax Gains Losses On Remeasurements of Defined Benefit Plans | €4.9M | -€11.2M |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net of Tax | -€400.0K | €13.3M |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net of Tax | €5.4M | -€11.0M |
| Other Current Assets | €260.7M | €269.3M |
| Other Current Liabilities | €811.1M | €830.9M |
| Other Finance Cost | €15.7M | €29.6M |
| Other Finance Income | €3.5M | €2.3M |
| Other Finance Income Cost | -€12.2M | -€27.3M |
| Other Individually Immaterial Components of Other Comprehensive Income Net of Tax | €500.0K | €200.0K |
| Other Longterm Provisions | €139.4M | €144.1M |
| Other Noncurrent Financial Assets | €160.0M | €146.9M |
| Other Noncurrent Liabilities | €16.2M | €7.4M |
| Other Operating Income Expense | -€570.7M | -€534.7M |
| Payments For Debt Issue Costs | €14.2M | €0 |
| Proceeds From Issuing Other Equity Instruments | €0 | €0 |
| Proceeds From Issuing Shares | €0 | €0 |
| Profit Loss From Discontinued Operations | -€3.1M | €0 |
| Rental Expense | €87.4M | €82.0M |
| Retained Earnings Profit Loss For Reporting Period | -€54.1M | -€53.9M |
| Share of Profit Loss of Associates Accounted For Using Equity Method | €0 | €0 |
| Share Premium | €611.2M | €611.2M |
| Tax Expense Other Than Income Tax Expense | €148.5M | €144.2M |
| Trade and Other Current Payables To Trade Suppliers | €432.3M | €457.8M |
Methodology
Every line item above is a fact tagged in RAMSAY GENERALE DE SANTE's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.